Anti-MS4A1 (Veltuzumab)-CL2A-SN-38 ADC

This ADC product is comprised of an anti-MS4A1 monoclonal antibody (Veltuzumab) conjugated via a CL2A linker to a SN-38. The SN-38 is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, SN-38 binds to DNA, causes DNA damage.